https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Interactions with the macrophages: an emerging targeted approach using novel drug delivery systems in respiratory diseases https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:37230 Wed 19 Jan 2022 15:15:18 AEDT ]]> Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:38204 Wed 18 Aug 2021 09:53:13 AEST ]]> Targeting eosinophils in respiratory diseases: biological axis, emerging therapeutics and treatment modalities https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46370 Wed 16 Nov 2022 08:45:58 AEDT ]]> TLR2-mediated innate immune priming boosts lung anti-viral immunity https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48671 Tue 28 Mar 2023 10:25:49 AEDT ]]> Increasing complexity and interactions of oxidative stress in chronic respiratory diseases: an emerging need for novel drug delivery systems https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47625 Tue 24 Jan 2023 14:02:31 AEDT ]]> Patented therapeutic drug delivery strategies for targeting pulmonary diseases https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46320 Tue 15 Nov 2022 15:56:23 AEDT ]]> Back to the Eosinophil: Resolvin Spatiotemporal Regulation https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54156 Tue 06 Feb 2024 12:11:30 AEDT ]]> Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45297 Thu 27 Oct 2022 15:02:18 AEDT ]]> The phosphorylated form of FTY720 activates PP2A, represses inflammation and is devoid of S1P agonism in A549 lung epithelial cells https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:26728 Thu 24 Mar 2022 11:33:42 AEDT ]]> Targeting MicroRNA function in respiratory diseases: mini-review https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29352 Thu 17 Mar 2022 14:39:11 AEDT ]]> Immunological axis of berberine in managing inflammation underlying chronic respiratory inflammatory diseases https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:39904 Thu 14 Jul 2022 11:58:51 AEST ]]> MicroRNAs in lung diseases https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36721 Thu 03 Feb 2022 12:20:36 AEDT ]]> Employment of microRNA profiles and RNA interference and antagomirs for the characterization and treatment of respiratory disease https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:22118 Sat 24 Mar 2018 07:13:18 AEDT ]]> Rhinoscleroma in Zambia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34165 Mon 23 Sep 2019 13:57:30 AEST ]]> Oligonucleotide therapy: an emerging focus area for drug delivery in chronic inflammatory respiratory diseases https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48492 Mon 20 Mar 2023 12:13:02 AEDT ]]> Targeting neutrophils using novel drug delivery systems in chronic respiratory diseases https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:44177 Mon 10 Oct 2022 10:20:24 AEDT ]]>